Top

American Journal of Clinical Dermatology

Published in:

01-06-2001 | Current Opinion

Photoprotection by Sunscreens

Authors: Lubomira Scherschun, Dr Henry W. Lim

Published in: American Journal of Clinical Dermatology | Issue 3/2001

Abstract

Ultraviolet (UV) radiation is an etiologic factor for the development of nonmelanoma skin cancers and also possibly melanoma. The American Academy of Dermatology currently recommends the daily use of sunscreens with a sun protection factor (SPF) of 15 or above. The SPF numerical rating is an in vivo, standardized measure of sunscreen efficacy. SPF assessment predominantly reflects the ability of a product to screen UVB radiation. The physical and biologic properties of UVA radiation are relevant as UVA contributes to photoimmunosuppression and photocarcinogenesis. An ideal sunscreen assessment system would address both UVB and UVA protection. However, the SPF rating should continue to serve as the major determinant of sunscreen efficacy.

Skin Cancer Foundation website. Available from URL: http//skincancer.org. Accessed 2000, October 14

American Melanoma Foundation website. Available from URL: http//melanomafoundation.org. Accessed 2000, October 15

Griffin M.E., Bourget T.D., Lowe N.J. Sun protection factor determination in the United States. In: Lowe N.J., Shaath N.A., Pathak M.A., editors. Sunscreens: development, evaluation and regulatory aspects. New York: Marcel Dekker, 1997: 499–512

Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170–175PubMedCrossRef

Thompson S.C., Jolley D., Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329 (16): 1147–1151PubMedCrossRef

Gallagher R.P., Rivers J.K., Lee T.K., et al. Broad-spectrum sunscreen use and the development of new nevi in white children. JAMA 2000; 22: 2955–2960CrossRef

Pruim B., Green A. Photobiological aspects of sunscreen re-application. Aust J Dermatol 1999; 40 (1): 14–18CrossRef

Wulf H.C., Stender I.M., Lock-Anderson J. Sunscreens used at the beach do not protect against erythema: a new definition of SPF is proposed. Photodermatol Photoimmunol Photomed 1997; 13 (4): 129–132PubMedCrossRef

Stenberg C., Larko O. Sunscreen application and its importance for the sun protection factor. Arch Dermatol 1985; 121 (11): 1400–1402PubMedCrossRef

10.

Westerdahl J., Olsson H., Masback A., et al. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995; 5: 59–65PubMedCrossRef

11.

Huncharek M., Kupelnick B. Use of topical sunscreen and the risk of malignant melanoma. Results of a meta-analysis of 9,067 patients. Ann Epidemiol 2000; 10 (7): 467PubMedCrossRef

12.

Bigby M. The sunscreen and melanoma controversy. Arch Dermatol 2000; 136 (3): 423CrossRef

13.

Kochevar I.E., Pathak M.A., Parrish J.A. Photophysics, photochemistry and photobiology. In: Freedberg I.M., Eisen A.Z., Wolff K., et al., editors. Dermatology in general medicine. 5th ed. New York: McGraw-Hill Inc., 1999: 220–229

14.

Fourtanier A., Gueniche A., Compan D., et al. Improved protection against solar-simulated radiation-induced immunosuppression by a sunscreen with enhanced ultraviolet A protection. J Invest Dermatol 2000; 114: 620–627PubMedCrossRef

15.

Van der Molen R.G., Out-Luiting C., Driller H., et al. Broad-spectrum sunscreens offer protection against urocanic acid photoisomeration by artificial ultraviolet radiation in human skin. J Invest Dermatol 2000; 115 (3): 421–426PubMedCrossRef

16.

Setlow R.B., Grist E., Thompson K., et al. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci 1993; 90: 6666–6670PubMedCrossRef

17.

Freeman S.E., Gange R.W., Sutherland J.C., et al. Production of pyrimidine dimers in DNA of human skin exposed in situ to UVA radiation. J Invest Dermatol 1987; 88 (4): 430–433PubMedCrossRef

18.

Drobetsky E.A., Turcotte J., Chateauneuf A. A role for ultraviolet A solar mutagenesis. Proc Natl Acad Sci 1995; 92: 2350–2354PubMedCrossRef

19.

Lavker R.M., Gerberick G.F., Veres D., et al. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1991; 32: 53–62CrossRef

20.

Lowe N.J. Ultraviolet A claims and tesing procedures for OTC sunscreens: a summary and review. In: Lowe N.J., Shaath N.A., Pathak M.A., editors. Sunscreens: development, evaluation and regulatory aspects. New York: Marcel Dekker, 1997: 527–535

21.

Chardon A., Moyal D., Hourseau C. Persistent pigment-darkening response as a method for evaluation of ultraviolet A protection assays. In: Lowe N.J., Shaath N.A., Pathak M.A., editors. Sunscreens: development, evaluation and regulatory aspects. New York: Marcel Dekker, 1997: 559–582

22.

Lim HW, Naylor M, Hönigsmann H, et al. American Academy of Dermatology Consensus Conference on UVA Protection of Sunscreens: summary and recommendations. J Am Acad Dermatol [In press]

Title: Photoprotection by Sunscreens
Authors: Lubomira Scherschun
Dr Henry W. Lim
Publication date: 01-06-2001
Publisher: Springer International Publishing
Published in: American Journal of Clinical Dermatology / Issue 3/2001
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI: https://doi.org/10.2165/00128071-200102030-00001

At a glance: The STEP trials

Springer Medicine

Photoprotection by Sunscreens

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2001

Estrogen and Skin

Drug-Induced Urticaria

Cutaneous Drug Reaction Case Reports

Topical Eflornithine

Topical Eflornithine

Vitiligo